5AM Ventures and Lundbeckfond Ventures led the $16 million Series A round for scPharmaceuticals, a pharmaceutical firm that is establishing products for subcutaneous delivery, a statement about the funding said.
Lundbeckfond Ventures
Breaking News
Thesan Pharmaceuticals, a biotech firm that develops therapies for skin conditions, raised $49 million for its Series B round led by existing investor Novo Ventures and joined in by SV Life Sciences, Lundbeckfond Ventures and Novartis Venture Fund.
Subscribe to VCpost newsletter
Most Popular
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- Brazilian Woman Wheels Her Dead Uncle Into the Bank to Withdraw Loan in His Name
- Trump Media’s First Auditor Quits After Just a Few Months on the Job: Report
- Tesla Spends $200,000 in Promoting Elon Musk's Social Media Platform X Following Mention of 'Minimal Advertising Efforts'
- UPDATE: Google Employees Arrested and Fired After Staging Protests Over Company's Project Nimbus Deal With Israel
- Social Security Benefits: 2025 COLA Predicted to Increase Amid Rising Inflation
- Spirit Airlines Staff at Florida Airport Filmed Cursing a 'Karen' Passenger After Moaning About Her Flight
- Navigating Tariff Tides: A Conversation with Jim Pratt on Supply Chain Strategies Ahead of 2024 Elections
